Skip to main content
Equibles

Headlands Technologies LLC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1570271 CHICAGO, IL
Back to RXRX Full portfolio

Position in RXRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,423,038
+$109,573 QoQ
Shares Held
387,749
-9.4% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#64
of 344 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Headlands Technologies LLC holds $60,689,199 across 67 Biotechnology names. RXRX ranks #11 (2.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 10,545 $6,575,229
2 RPRX
Royalty Pharma plc
 90,729 $5,087,175
3 INSM
INSMED Inc
 40,855 $4,355,960
4 BNTX
BioNTech SE
 27,087 $2,520,445
5 NAMS
NewAmsterdam Pharma Co N.V.
 72,335 $2,451,433
6 IBRX
ImmunityBio, Inc.
 248,550 $2,176,055
7 ABCL
AbCellera Biologics Inc.
 246,252 $1,933,078
8 NVAX
Novavax Inc
 190,547 $1,794,952

All Filings in RXRX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,423,038 387,749
2026-03-31 $1,313,465 427,839
2025-12-31 $946,720 231,472
2025-09-30 $922,910 189,121
2025-06-30 $1,009,039 199,415
2025-03-31 $877,346 165,850
2024-12-31 $603,762 89,314
2024-09-30 $198,378 30,103
2024-06-30 $173,190 23,092